Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

If you take the drug Humira to treat the skin condition plaque psoriasis, the cost is $35,000 annually. If you have insurance where you work, as more than 156 million Americans do, it will foot ...

Blue Shield is teaming up with drugmaker Fresenius Kabi and Evio Pharmacy Solutions to purchase a biosimilar for Humira at a transparent net price of $525 per monthly dose.

Humira's patent expired in January 2023, opening the door for lower-cost biosimilars. However, prices haven't decreased as much as expected in a functioning market, limiting widespread adoption.

SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), ... New low-cost Humira and Stelara biosimilars specifically for pediatric members: ...

Mark Cuban Cost Plus Drug Company and Coherus BioSciences are planning to offer customers Yusimry (adalimumab-aqvh), a biosimilar of AbbVie's Humira (adalimumab injection), in July 2023.

Blue Shield of California partners with Fresenius Kabi and Evio Pharmacy to cut the cost of Humira's biosimilar to $525 per month, with most members paying $0 out of pocket starting January 2025.

When Abbott announced its full-year results last week, its anti-TNF inhibitor product Humira delivered a stronger-than-expected 23.1 percent year-on-year increase in Q4 sales (recorded at $2.7 ...

One is even offering Humira biosimilars to members for free. AbbVie, PBMs cut out in Evio's generic Humira-to-insurer deal | Crain's Chicago Business Skip to main content ...

Humira’s $200 billion in global sales make it the best-selling drug in history. Its manufacturer, ... Prescryptive, a small PBM that promises transparent policies, switched 100% of its patients after ...

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

Tennessee last year spent $48 million on a single drug, Humira—about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.